Ostrum Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Sell |
21,087
-235
| -1% | -$12.9K | 0.05% | 269 |
|
|
2025
Q1 | $1.51M | Sell |
21,322
-224
| -1% | -$15.8K | 0.08% | 228 |
|
|
2024
Q4 | $1.42M | Sell |
21,546
-12,103
| -36% | -$796K | 0.12% | 255 |
|
|
2024
Q3 | $2.37M | Buy |
33,649
+253
| +0.8% | +$17.8K | 0.2% | 187 |
|
|
2024
Q2 | $2.75M | Sell |
33,396
-1,596
| -5% | -$131K | 0.24% | 139 |
|
|
2024
Q1 | $3.06M | Hold |
34,992
| – | – | 0.24% | 125 |
|
|
2023
Q4 | $3.37M | Sell |
34,992
-6,179
| -15% | -$596K | 0.29% | 94 |
|
|
2023
Q3 | $3.64M | Sell |
41,171
-2,139
| -5% | -$189K | 0.34% | 70 |
|
|
2023
Q2 | $3.75M | Sell |
43,310
-250
| -0.6% | -$21.7K | 0.31% | 86 |
|
|
2023
Q1 | $4.24M | Buy |
+43,560
| New | +$4.24M | 0.37% | 68 |
|
|
2020
Q3 | $1.52M | Buy |
20,000
+8,500
| +74% | +$647K | 0.98% | 24 |
|
|
2020
Q2 | $1.42M | Buy |
+11,500
| New | +$1.42M | 0.84% | 29 |
|